Ultrasound contrast agent with nanoparticles including drug and method for preparing the same
US-2015343079-A1 · Dec 3, 2015 · US
US9993440B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9993440-B2 |
| Application number | US-201214342524-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 4, 2012 |
| Priority date | Sep 2, 2011 |
| Publication date | Jun 12, 2018 |
| Grant date | Jun 12, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides methods of making and using compositions comprising a polymer shell designed to deliver polypeptides to selected environments. In embodiments of the invention, different environmental conditions are harnessed to allow the selective degradation of the polymer shell and the consequential release of one or polypeptides encapsulated therein. In illustrative embodiments, polymer components of the shell are interconnected by peptide-containing crosslinker moieties, linkages which maintain the integrity of the polymer shell under certain environmental conditions, but can also be cleaved when combined with a selected protease.
Opening claim text (preview).
The invention claimed is: 1. A composition of matter comprising: at least one polypeptide; a polymeric network, wherein: polymers in the polymeric network are coupled together by a first crosslinking agent and a second crosslinking agent so as to form a shell that encapsulates the polypeptide; the first crosslinking agent comprises a peptide having an amino acid sequence that is cleaved by a protease, wherein amino acid sequence that is cleaved by the protease comprises KNRVK (SEQ ID NO: 1), GGIPVSLRSGGK (SEQ ID NO: 2) or GGVPLSLYSGGK (SEQ ID NO: 3); and the second crosslinking agent does not comprise a peptide having an amino acid sequence that is cleaved by a protease; wherein the polymers, the first crosslinking agent and the second crosslinking agent are disposed within the polymeric network in an orientation so that proteolytic cleavage of the first crosslinking agent releases the polypeptide from the shell into an external environment. 2. The composition of claim 1 , wherein relative molar amounts of the first crosslinking agent and the second crosslinking agent in the shell are at least 1:5, 1:4, 1:3, 1:2, 1:1, 2:1, 3:1, 4:1 or 5:1. 3. The composition of claim 1 , wherein shell that encapsulates the polypeptide has a diameter between 15 and 35 nanometers. 4. The composition of claim 1 , wherein the polypeptide comprises a protein that stimulates cellular growth. 5. The composition of claim 1 , wherein the composition further comprises a hydrogel in which the shell is disposed. 6. The composition of claim 5 , wherein the shell is covalently coupled to the hydrogel by a hydrogel crosslinking agent. 7. The composition of claim 6 , wherein the hydrogel crosslinking agent comprises a peptide having an amino acid sequence that is cleaved by a protease. 8. The composition of claim 1 , wherein the first crosslinking agent comprises a peptide having D-amino acids. 9. The composition of claim 1 , wherein the concentration of the first crosslinking agent in the composition relative to the concentration of the second crosslinking agent in the composition is controlled so as to modulate the rate at which the polypeptide is released from the shell into an external in vivo environment. 10. The composition of claim 9 , wherein the concentration of the first crosslinking agent is greater than the concentration of the second crosslinking agent in order to modulate the rate at which the polypeptide is released from the shell into an external in vivo environment. 11. The composition of claim 9 , wherein the concentration of the first crosslinking agent is less than the concentration of the second crosslinking agent in order to modulate the rate at which the polypeptide is released from the shell into an external in vivo environment. 12. A composition of matter comprising: at least two polypeptides; a polymeric network, wherein: polymers in the polymeric network are coupled together by a first crosslinking agent and a second crosslinking agent so as to form a shell that encapsulates the at least two polypeptides; the first crosslinking agent comprises a peptide having an amino acid sequence that is cleaved by a protease, wherein amino acid sequence that is cleaved by the protease comprises KNRVK (SEQ ID NO: 1), GGIPVSLRSGGK (SEQ ID NO: 2) or GGVPLSLYSGGK (SEQ ID NO: 3); and the second crosslinking agent does not comprise a peptide having an amino acid sequence that is cleaved by the protease; wherein the polymers, the first crosslinking agent and the second crosslinking agent are disposed within the polymeric network in an orientation so that proteolytic cleavage of the first crosslinking agent releases the at least two polypeptides from the shell into an external environment.
Processes · CPC title
Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers · CPC title
lyophilised {, i.e. freeze-dried, solutions or dispersions (lyophilised products with subsequent particle size reduction A61K9/14; granules or pellets made by lyphilisation A61K9/1682; solid oral dosage forms made by lyophilisation A61K9/2095; lyophilisation additives A61K47/00)} · CPC title
Proteins, e.g. albumin, gelatin · CPC title
obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.